elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Heparin
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Heparin
RIS
0.003
(Research Intensity Score)
Papers
379
Top papers
Recurrent MiscarriageGreen‐top Guideline No. 17
2023 · 150 citations
Multifunctional Polymer‐Regulated SnO 2 Nanocrystals Enhance Interface Contact for Efficient and Stable Planar Perovskite Solar Cells
2020 · 324 citations
Nitric Oxide‐Driven Nanomotor for Deep Tissue Penetration and Multidrug Resistance Reversal in Cancer Therapy
2020 · 186 citations
Targeted nanoparticles triggered by plaque microenvironment for atherosclerosis treatment through cascade effects of reactive oxygen species scavenging and anti-inflammation
2024 · 33 citations
Electrodeposited Hydroxyapatite-Based Biocoatings: Recent Progress and Future Challenges
2021 · 153 citations
Newest papers
Ultrasensitive electrochemiluminescence aptasensor for heparin-binding protein based on hybridization chain reaction (HCR) amplification and magnetic enrichment
2026 · 2 citations
Intravesical therapy for recurrent urinary tract infection: a systematic review and meta‐analysis
2026 · 1 citations
Amplification of seeding-competent tau aggregates by PMCA in human and experimental tauopathies
2026
Research Progress on FGF1-Mediated STFS in Skin Wound Repair
2026
Elucidating the role of Von Willebrand Factor in multiple myeloma disease biology
2026
A sample from the 100 top papers behind Heparin.
Create a free account to browse them all →
Heparin's history
Research intensity over time
Explore Heparin's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Heparin's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link